Related Experiment Video
Updated: Jul 23, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
Worldwide epidemiology of HBV infection, disease burden, and vaccine prevention
1World Health Organization, Department of Communicable Diseases Surveillance and Response, Geneva, Switzerland.
Insights
Hepatitis B virus (HBV) causes chronic liver infections and hepatocellular carcinoma (HCC) globally. Hepatitis B vaccination can prevent HBV transmission and its severe complications, making elimination a feasible public health goal.
Area of Science:
- Hepatology
- Virology
- Public Health
Background:
- Hepatitis B virus (HBV) is the most prevalent cause of chronic liver infections worldwide.
- Chronic HBV infection is a leading cause of hepatocellular carcinoma (HCC), posing a significant global health challenge.
- A large reservoir of chronically infected individuals contributes to ongoing transmission and severe liver disease complications.
Purpose of the Study:
- To highlight the global public health impact of chronic hepatitis B virus infections.
- To emphasize the link between HBV and hepatocellular carcinoma.
- To underscore the preventability of HBV and its complications through vaccination.
Main Methods:
- Literature review on HBV epidemiology and disease burden.
- Analysis of HBV's role in hepatocellular carcinoma etiology.
- Assessment of hepatitis B vaccination as a public health intervention.
Main Results:
- HBV is the most common hepatitis virus causing chronic infections and HCC globally.
- Ongoing new infections and a large reservoir of chronically infected individuals sustain the public health problem.
- Hepatitis B and D (HDV) infections and their complications are preventable through vaccination.
Conclusions:
- Elimination of HBV transmission and new infections is achievable through widespread vaccination.
- Hepatitis B vaccination is a critical tool for preventing chronic liver disease and hepatocellular carcinoma.
- Public health strategies should focus on vaccination to control the global burden of hepatitis B.
Abstract:
Worldwide, hepatitis B virus (HBV) is the most common among those hepatitis viruses that cause chronic infections of the liver in humans, and it represents a global public health problem. Chronic hepatitis caused by HBV is the major cause of hepatocellular carcinoma (HCC) worldwide, and remains therefore a major public health problem globally. This fact is related to both the continuing occurrence of frequent new infections and to the presence of a large reservoir of persons chronically infected, which may develop severe and fatal complications of chronic liver disease. Hepatitis B and all of the complications resulting from it, as well hepatitis D (HDV) and its complications, are globally preventable by hepatitis B vaccination, and therefore elimination of HBV transmission and of new acute and chronic infections is a feasible goal.
Related Concept Videos
Vaccinations
Smallpox
Yellow Fever
Hepatitis
Genital Herpes
Viral Hepatitis I: Introduction

